These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 16371024)

  • 41. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.
    Castriconi R; Cantoni C; Della Chiesa M; Vitale M; Marcenaro E; Conte R; Biassoni R; Bottino C; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4120-5. PubMed ID: 12646700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].
    Zhang C; Tian ZG; Zhang J; Feng JB; Zhang JH; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):324-7. PubMed ID: 15312339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
    Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NKG2D and cytotoxic effector function in tumor immune surveillance.
    Hayakawa Y; Smyth MJ
    Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Constitutively polarized granules prime KHYG-1 NK cells.
    Suck G; Branch DR; Aravena P; Mathieson M; Helke S; Keating A
    Int Immunol; 2006 Sep; 18(9):1347-54. PubMed ID: 16849396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
    Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
    Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
    Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP
    Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
    Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
    Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity.
    Vitale C; Chiossone L; Cantoni C; Morreale G; Cottalasso F; Moretti S; Pistorio A; Haupt R; Lanino E; Dini G; Moretta L; Mingari MC
    Eur J Immunol; 2004 Nov; 34(11):3028-38. PubMed ID: 15368269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.